When families hear that a loved one's cancer might be connected to a lifetime of smoking, they picture the lung, the throat, maybe the bladder. Almost no one pictures the bone marrow. So when a longtime smoker is diagnosed with acute myeloid leukemia — a cancer of the blood — the connection to cigarettes usually never comes up, not from the family and often not from anyone else. That silence is not because the link is speculative. It is because the link is simply not well known outside the pages of the Surgeon General's reports.
Here is the fact those reports settled more than twenty years ago: cigarette smoking causes acute myeloid leukemia. This piece explains what AML is, why a blood cancer earned a place on the official list of smoking-caused diseases, the single chemical that connects a cigarette to the bone marrow, what the epidemiology actually shows, why the "leukemia isn't a smoking cancer" defense does not survive contact with the science, and how these cases fit the same liability framework the firm uses in its lung cancer and COPD claims.
What Acute Myeloid Leukemia Is
Acute myeloid leukemia is a cancer that starts in the bone marrow — the spongy tissue inside bones where blood cells are made. In AML, the marrow produces abnormal, immature white blood cells (called myeloblasts, or "blasts") that never mature into functioning cells. These blasts multiply quickly and crowd out the normal production of red cells, healthy white cells, and platelets. "Acute" means it moves fast; untreated, AML can become life-threatening in weeks rather than years.
Because the disease attacks the blood-forming system itself, its early symptoms are easy to mistake for something ordinary: fatigue, shortness of breath, frequent or lingering infections, easy bruising or bleeding, fever, and bone or joint pain. Diagnosis typically comes from blood work followed by a bone marrow biopsy, and it is confirmed and subtyped through cytogenetic and molecular testing that reads the specific chromosomal changes inside the leukemia cells. AML is the most common form of acute leukemia in adults, and its incidence rises with age.
Why a Blood Cancer Is on the Smoking List
The authority here is not a plaintiff's lawyer or an advocacy group. It is the office of the U.S. Surgeon General. The 2004 Surgeon General's report on the health consequences of smoking concluded that the evidence is sufficient to infer a causal relationship between cigarette smoking and acute myeloid leukemia — the government's highest tier of scientific certainty. The landmark 2014 report reaffirmed AML's place on the roster of smoking-caused cancers, and the National Cancer Institute today lists acute myeloid leukemia alongside lung, esophagus, larynx, mouth, throat, kidney, bladder, liver, pancreas, stomach, cervix, colon, and rectum among the cancers that smoking causes.
In other words, AML is not a fringe or theoretical smoking injury. It sits on exactly the same official list as lung cancer. The only reason it feels like a surprise is that the public conversation about smoking has always centered on the lungs and the airway, where the smoke is visible and the damage is intuitive. The bone marrow is invisible, and so is the pathway that reaches it.
Benzene: The Carcinogen That Connects the Cigarette to the Bone Marrow
The reason smoking causes a blood cancer comes down to one chemical: benzene. Benzene is not an exotic contaminant. It is a well-characterized industrial carcinogen, and it is a routine constituent of cigarette smoke.
- Benzene causes AML — that is the settled classification. The International Agency for Research on Cancer classifies benzene as "carcinogenic to humans" (Group 1) based on sufficient evidence that it causes acute myeloid leukemia. It is one of the most thoroughly established human leukemogens in existence — the chemical behind the classic occupational leukemias in refinery, chemical, and shoe-industry workers.
- Cigarettes are a leading source of it. According to public-health assessments of benzene exposure, about half of the total U.S. population's exposure to benzene comes from cigarette smoke. Among people who smoke, roughly 90% of their benzene exposure comes from smoking. Measured blood-benzene levels are markedly higher in smokers than in non-smokers.
- It reaches the marrow. Inhaled benzene is absorbed into the bloodstream and metabolized, and its metabolites are toxic to the bone marrow — damaging blood-forming stem cells, disrupting DNA, and producing the kinds of chromosomal abnormalities seen in AML. This is the biological bridge from the cigarette to the diagnosis.
Put those facts side by side and the picture is stark. The same Group 1 carcinogen that triggers workers'-compensation and toxic-tort leukemia claims when it comes out of an industrial process is delivered, dose after dose, in cigarette smoke — and the companies that manufactured the cigarettes have known their product contained it for decades.
What the Numbers Show
The epidemiology tracks the biology. The most comprehensive synthesis is a 2014 meta-analysis published in the American Journal of Hematology, which pooled 23 studies covering 7,746 cases of acute myeloid leukemia. Its findings:
- Current smokers carried a 40% higher risk of developing AML than non-smokers (relative risk 1.40, 95% confidence interval 1.22–1.60).
- Ever-smokers (anyone who had smoked) carried a 25% higher risk (relative risk 1.25, 95% confidence interval 1.15–1.36).
- The risk climbed with smoking intensity — a dose-response pattern, which is one of the classic signatures epidemiologists look for when deciding whether an association reflects genuine causation rather than coincidence.
A 40% increase may sound smaller than the several-fold risks seen in lung or laryngeal cancer, and it is. But it is a real, consistent, dose-related elevation confirmed across dozens of studies and thousands of patients, and it applies to a fast-moving, frequently fatal cancer. For an individual who smoked heavily for decades and then developed AML, that population-level signal is the backdrop against which a specific case is evaluated.
The "Leukemia Isn't a Smoking Cancer" Defense — and Why It Does Not End the Case
Because the smoking–AML link is so little known, tobacco defendants lean on the public's disbelief. The argument is essentially: everyone knows smoking hurts the lungs, but leukemia? That is just bad luck, or something in the patient's past, not our cigarettes. The argument trades on unfamiliarity, and it does not hold up.
First, the causal conclusion is the government's, not the plaintiff's — the Surgeon General and the National Cancer Institute both classify AML as smoking-caused. Second, the mechanism is not mysterious; it is benzene, a carcinogen IARC has already found sufficient to cause AML, and cigarettes are a dominant source of it. Third, when a defense points to other possible benzene or chemical exposures — a job, an environment — that argument cuts both ways: it concedes that benzene causes this disease, and it invites a careful accounting of how much of a particular patient's benzene load came from a pack-a-day habit versus anything else. In product-liability law, a manufacturer whose product was a substantial contributing factor does not escape liability by naming another factor that shared the stage.
This is precisely the kind of record where the firm's Medical-Legal Expert earns his place. Herb Borroto, M.D., J.D., who holds both a medical degree and a law degree, reads the bone marrow pathology, the cytogenetic and molecular reports, any prior myelodysplastic syndrome (MDS) that preceded the AML, the occupational and exposure history, and the smoking record together — separating the parts of the causal story that support a claim from the parts a defense expert will attack, in a way a purely legal review has no reason to frame and a purely clinical review has no reason to connect to liability.
The Legal Framework
Smoking-related AML cases proceed on the same liability theories as other smoking-disease cases against the tobacco industry:
- Negligent design, manufacture, and marketing of cigarettes.
- Strict product liability for an unreasonably dangerous product.
- Failure to warn about the carcinogenic constituents — benzene among them — and the addictive properties of cigarette smoke.
- Fraud and misrepresentation about the safety and addictiveness of the products.
- Civil conspiracy among manufacturers to suppress and distort health research.
The internal industry records unearthed in prior tobacco litigation — the documents showing what the companies knew about the chemistry of their smoke and when — remain central evidence, and the presence of a named human carcinogen in that smoke is part of that story. Our companion piece on how tobacco companies hid the truth walks through that record. Alex Alvarez, the firm's Managing Partner and a Board Certified Civil Trial Lawyer, brings that documentary record together with each client's own smoking and diagnosis history to build the causation case an AML claim requires — including the response to the "leukemia isn't a smoking cancer" defense described above.
What an AML Case Needs
- A documented diagnosis of acute myeloid leukemia, supported by the bone marrow biopsy, blood work, and the cytogenetic and molecular subtyping.
- A substantial smoking history, measured in pack-years.
- Brand identification — which cigarettes were smoked, and for how long.
- The occupational and environmental history, so any additional benzene exposures can be accounted for rather than left as an open door for the defense.
- Any prior hematologic condition, such as MDS, that preceded and may have evolved into the AML.
- Causation testimony from an appropriate expert familiar with the benzene–leukemia and tobacco–AML literature.
- Documentation of the disease's impact — induction chemotherapy, hospitalization, transfusions, any stem-cell transplant, and the effect on daily life.
- For cases brought after a death, the cause-of-death records and the disease-course documentation.
The unglamorous paperwork behind these elements is what carries a case. Our guide to smoking history documentation covers the records that build or break a tobacco claim.
The Jurisdictions We Serve
The Alvarez Law Firm represents smokers and families in Hawaii, Illinois, Nevada, Oregon, Pennsylvania, and the U.S. Virgin Islands. Each of those jurisdictions has its own filing deadlines, its own substantive law on tobacco product liability, and its own version of the discovery rule — how long after diagnosis a claim must be filed when the connection to smoking was not initially apparent. Because the smoking–AML link is so unfamiliar, many families never suspect the connection until long after the diagnosis, which makes the timing questions in these cases especially important. Talk to counsel licensed in the relevant state about how those deadlines apply to your situation. Waiting can foreclose options that were available earlier.
Frequently Asked Questions
Does smoking cause leukemia?
Yes, for one specific type. The U.S. Surgeon General concluded in 2004 that the evidence is sufficient to infer a causal relationship between cigarette smoking and acute myeloid leukemia (AML), and the National Cancer Institute lists AML among the cancers caused by smoking. The link runs through benzene, a known bone-marrow carcinogen present in cigarette smoke. Smoking is most clearly tied to AML in adults; the evidence for other adult leukemias is weaker.
How much does smoking raise the risk of AML?
A 2014 meta-analysis in the American Journal of Hematology pooled 23 studies covering 7,746 AML cases and found that current smokers carried a 40% higher risk of AML than non-smokers (relative risk 1.40, 95% confidence interval 1.22 to 1.60) and ever-smokers a 25% higher risk (relative risk 1.25, 95% confidence interval 1.15 to 1.36), with risk rising as smoking intensity increased.
Why would a blood cancer be a smoking case at all?
Because cigarette smoke contains benzene, which the International Agency for Research on Cancer classifies as carcinogenic to humans based on sufficient evidence that it causes AML. About half of the total U.S. population's benzene exposure comes from cigarette smoke, and among smokers roughly 90% of benzene exposure comes from smoking. The same carcinogen that causes occupational leukemia in benzene-exposed workers is inhaled with every cigarette.
If You or a Family Member Has AML
If you have a substantial smoking history and have been diagnosed with acute myeloid leukemia — even if no one ever mentioned a connection to cigarettes — a free, confidential case review is the right next step. The same conversation that produces a viable lung cancer or COPD case can produce a viable AML case, and the bone marrow and cytogenetic reports usually hold the first clue.
- Read the companion piece on another benzene-linked smoking cancer: Smoking and Bladder Cancer.
- Read about esophageal cancer cases: Smoking and Esophageal Cancer.
- See the practice-area overview of other smoking cancers: Other Smoking-Related Cancers.
- Read about lung cancer cases: Lung Cancer Smoking Lawsuit Legal Rights.
- Read the wrongful death family guide: Smokers Wrongful Death Family Guide.
Free case review. No fees unless we recover compensation for you.
Sources
- U.S. Surgeon General — "The Health Consequences of Smoking: A Report of the Surgeon General" (2004), concluding a causal relationship between smoking and acute myeloid leukemia; reaffirmed in "The Health Consequences of Smoking — 50 Years of Progress" (2014). cdc.gov/tobacco
- National Cancer Institute — "Harms of Cigarette Smoking and Health Benefits of Quitting," listing acute myeloid leukemia among the cancers caused by smoking. cancer.gov
- Fircanis S, Merriam P, Khan N, Castillo JJ. "The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies." American Journal of Hematology, 2014. pubmed.ncbi.nlm.nih.gov
- International Agency for Research on Cancer / National Cancer Institute — Benzene classified as carcinogenic to humans (Group 1) based on sufficient evidence for acute myeloid leukemia. cancer.gov/benzene
- American Cancer Society — "Benzene and Cancer Risk," on benzene in cigarette smoke and its share of population exposure. cancer.org